| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/EJI.1830181222 |
| P698 | PubMed publication ID | 2464496 |
| P50 | author | Josephine H Cox | Q64869594 |
| P2093 | author name string | Francis MJ | |
| Lamb JR | |||
| Young DB | |||
| Ivanyi J | |||
| Syred AD | |||
| P2860 | cites work | General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids | Q24612820 |
| Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins | Q27860987 | ||
| Function of macrophages in antigen recognition by guinea pig T lymphocytes. I. Requirement for histocompatible macrophages and lymphocytes | Q36272607 | ||
| Protective immunogenicity and T lymphocyte specificity of a trivalent hybrid peptide containing NH2-terminal sequences of types 5, 6, and 24 M proteins synthesized in tandem | Q36353910 | ||
| Influences of antigen processing on the expression of the T cell repertoire. Evidence for MHC-specific hindering structures on the products of processing | Q36355124 | ||
| Efficient mapping of protein antigenic determinants | Q37399826 | ||
| A recombinant 64 kilodalton protein of Mycobacterium bovis bacillus Calmette-Guerin specifically stimulates human T4 clones reactive to mycobacterial antigens | Q41815508 | ||
| The functional dissection of an antigen molecule: specificity of humoral and cellular immune responses to glucagon | Q42002697 | ||
| Antibody response in pig nasal fluid and serum following foot-and-mouth disease infection or vaccination | Q42110704 | ||
| Enumeration of T cells reactive with Mycobacterium tuberculosis organisms and specific for the recombinant mycobacterial 64-kDa protein | Q44601613 | ||
| Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein | Q44806763 | ||
| Immunological priming with synthetic peptides of foot-and-mouth disease virus | Q45837948 | ||
| Fusion proteins with multiple copies of the major antigenic determinant of foot-and-mouth disease virus protect both the natural host and laboratory animals | Q45847788 | ||
| Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants | Q45847888 | ||
| Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site | Q45847909 | ||
| Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein | Q47645821 | ||
| The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation. | Q51023960 | ||
| Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. | Q51186886 | ||
| Protection of cattle against foot-and-mouth disease by a synthetic peptide. | Q53889573 | ||
| Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide | Q55869789 | ||
| Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence | Q59068267 | ||
| Binding of immunogenic peptides to Ia histocompatibility molecules | Q59070314 | ||
| A synthetic vaccine constructed by copolymerization of B and T cell determinants | Q68988248 | ||
| Engineering of immunogenic peptides by co-linear synthesis of determinants recognized by B and T cells | Q69002035 | ||
| Enhancement of peptide immunogenicity by linear polymerization | Q69021622 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 2015-2019 | |
| P577 | publication date | 1988-12-01 | |
| P1433 | published in | European Journal of Immunology | Q5412727 |
| P1476 | title | Orientation of epitopes influences the immunogenicity of synthetic peptide dimers | |
| P478 | volume | 18 |
| Q39878888 | A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants |
| Q28379265 | A strategy for rational design of fully synthetic glycopeptide conjugate vaccines |
| Q27486187 | A synthetic peptide to the E glycoprotein of Murray Valley encephalitis virus defines multiple virus-reactive T- and B-cell epitopes |
| Q67666655 | Antibodies raised against peptide fragments of bovine αs1-casein cross-react with the intact protein only when the peptides contain both B and T cell determinants |
| Q44089468 | Antibodies raised against peptide fragments of bovine αs1-casein cross-react with the native protein, but recognize sites distinct from the determinants on the protein |
| Q39340719 | Antibody responses to non-immunogenic synthetic peptides induced by co-immunization with immunogenic peptides |
| Q72070596 | Characterization of T-cell responses to the house dust mite allergen Der p II in mice. Evidence for major and cryptic epitopes |
| Q40308695 | Cross-reactive and serotype-specific antibodies against foot-and-mouth disease virus generated by different regions of the same synthetic peptide |
| Q34633581 | Delineation of the minimal hepatitis B surface antigen-specific B- and T-cell epitope contained within an anti-idiotype-derived pentadecapeptide |
| Q78066624 | Design of highly immunogenic liposomal constructs combining structurally independent B cell and T helper cell peptide epitopes |
| Q62657294 | Differences in secondary structure of HAV-synthetic peptides induced by the sequential order of T- and B-cell epitopes |
| Q69090096 | Differential pattern of T cell recognition of the 65-kDa mycobacterial antigen following immunization with the whole protein or peptides |
| Q67667689 | Enhanced immunogenicity of recombinant peptide fusions containing multiple copies of a heterologous T helper epitope |
| Q27486235 | Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes |
| Q40374626 | Epitope specificity and isoforms of the mycobacterial 19-kilodalton antigen |
| Q92051391 | Evaluating the immunogenicity of chemically-synthesised peptides derived from foot-and-mouth disease VP1, VP2 and VP3 proteins as vaccine candidates |
| Q38203257 | Function and Potentials of M. tuberculosis Epitopes |
| Q41292354 | H-2-associated effects of flanking residues on the recognition of a permissive mycobacterial T-cell epitope |
| Q36499432 | Heat Shock Proteins as Antigens of Bacterial and Parasitic Pathogens |
| Q40795523 | High and low responsiveness to vaccines in farm animals |
| Q41563249 | Human cartilage aggrecan CS1 region contains cryptic T-cell recognition sites |
| Q33565109 | Human cartilage proteoglycans as T cell autoantigens |
| Q39602247 | Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus. |
| Q46017381 | Immunization with a synthetic robustoxin derivative lacking disulphide bridges protects against a potentially lethal challenge with funnel-web spider (Atrax robustus) venom. |
| Q54375647 | Immunogenic comparison for two different recombinant chimeric peptides (CP12 and CP22) containing one or two copies of three linear B cell epitopes from β-hCG subunit |
| Q43565868 | Impact of epitope permutations in the antibody response of mice to a multi-epitope polypeptide of the V3 loop of human immunodeficiency virus type 1. |
| Q67691162 | Induction of antibodies against a peptide hapten does not require covalent linkage between the hapten and a class II presentable T helper peptide |
| Q72091601 | Induction of antibody responses to breast carcinoma associated mucins using synthetic peptide constructs as immunogens |
| Q39710931 | Induction of virus-specific neutralizing immune response against West Nile and Japanese encephalitis viruses by chimeric peptides representing T-helper and B-cell epitopes |
| Q40047371 | Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki Forest virus |
| Q45873996 | Molecular cloning and expression of the VP1 gene of foot-and-mouth disease virus C1 in E. coli: effect on bacterial cell viability |
| Q40640674 | Need for cellular and humoral immune responses in bovines to ensure protection from foot-and-mouth disease virus (FMDV)--a point of view |
| Q45851828 | Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides |
| Q73428233 | On the immunogenic properties of retro-inverso peptides. Total retro-inversion of T-cell epitopes causes a loss of binding to MHC II molecules |
| Q52065347 | Peptide‐induced memory (IgG) response, cross‐reactive with native proteins, requires covalent linkage of a specific B cell epitope with a T cell epitope |
| Q44693960 | Polarity of immunogens: implications for vaccine design |
| Q71617364 | Preferential pairing of T and B cells for production of antibodies without covalent association of T and B epitopes |
| Q45874977 | Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle |
| Q51837773 | Rapid Monoclonal Antibody Generation Via Dendritic Cell TargetingIn Vivo |
| Q44433947 | Recombinant fusion peptides containing single or multiple repeats of a ubiquitous T-helper epitope are highly immunogenic |
| Q62727136 | Simple strategy to induce antibodies of distinct specificity: Application to the mapping of gp120 and inhibition of HIV-1 infectivity |
| Q74497671 | Specificity of the T-cell responses in covalently linked peptides each comprising of a T helper epitope |
| Q27486548 | T-helper cell and associated antibody response to synthetic peptides of the E glycoprotein of Murray Valley encephalitis virus |
| Q39340678 | The influence of orientation and number of copies of T and B cell epitopes on the specificity and affinity of antibodies induced by chimeric peptides |
| Q74261407 | The specificity of antibodies raised against a T cell peptide is influenced by peptide amidation |
| Q67657519 | Treatment of adjuvant arthritis in rats: Vaccination potential of a synthetic nonapeptide from the 65 kDa heat shock protein of mycobacteria |
Search more.